+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In-vitro Colorectal Cancer Screening Tests Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 183 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5669467

Increaseing government initiatives such as Colorectal Cancer Control Program and insurance policies like Medicaid and Medicare are working toward providing colorectal cancer screening tests to many patients in the US

The Global In-vitro Colorectal Cancer Screening Tests Market is estimated to be USD 911.47 Mn in 2023 and is expected to reach USD 1284.97 Mn by 2028 growing at a CAGR of 7.11%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global In-vitro Colorectal Cancer Screening Tests Market is segmented based on Test Type, Imaging Type, End-User, and Geography.
  • By Test Type, the market is classified into Blood and Biopsy.
  • By Imaging Type, the market is classified into Colonoscopy, Proctoscopy, CT scan, Ultrasound, MRI, and PET Scan.
  • By End-User, the market is classified into Hospitals, Clinics, Diagnostics Laboratories, and Ambulatory Surgical Centres.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 3SBio, AbbVie Inc., Amgen, Astellas Pharma Inc., AstraZeneca, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global In-vitro Colorectal Cancer Screening Tests Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global In-vitro Colorectal Cancer Screening Tests Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global In-vitro Colorectal Cancer Screening Tests Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Incidence of Colon and Rectal Cancers
4.1.2 Growing Accuracy of Colorectal Cancer Screening by Use of Genetic Testing
4.1.3 Presence of a Number of Colorectal Cancer Screening Products in Pipeline
4.2 Restraints
4.2.1 Pending Investigational Evidence for Certain Genetic Screening Tests
4.2.2 Difficulty to Undertake CRC Screening Tests to Encompass the Entire
4.3 Opportunities
4.3.1 Growing R&D for developing advanced DNA sequencing methods such as hybridization, RNAP sequencing, microfluidic sequencing
4.4 Challenges
4.4.1 Lack of Trained Professionals in Developing Countries
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global In-vitro Colorectal Cancer Screening Tests Market, By Test Type
6.1 Introduction
6.2 Blood Test
6.2.1 Complete blood count
6.2.2 Liver enzyme function
6.2.3 Tumor marker test
6.2.4 Fecal Occult Blood Test
6.3 Biopsy
6.3.1 Gene tests
6.3.2 MMR tests
7 Global In-vitro Colorectal Cancer Screening Tests Market, By Imaging Type
7.1 Introduction
7.2 Colonoscopy
7.3 Proctoscopy
7.4 CT Scan
7.5 Ultrasound
7.6 MRI
7.7 PET Scan
8 Global In-vitro Colorectal Cancer Screening Tests Market, By End-User
8.1 Introduction
8.2 Hospitals
8.3 Clinics
8.4 Diagnostics Laboratories
8.5 Ambulatory Surgical Centers
9 Americas’ In-vitro Colorectal Cancer Screening Tests Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s In-vitro Colorectal Cancer Screening Tests Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s In-vitro Colorectal Cancer Screening Tests Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s In-vitro Colorectal Cancer Screening Tests Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 3SBio
14.2 AbbVie, Inc.
14.3 Amgen
14.4 Astellas Pharma, Inc.
14.5 AstraZeneca
14.6 Bayer
14.7 BeiGene
14.8 Bristol-Myers Squibb
14.9 Celgene
14.10 Cernostics
14.11 Cerus Corporation
14.12 CHAIN Biotechnology
14.13 Daiichi Sankyo
14.14 DNALite Therapeutics, Inc.
14.15 Eli Lilly
14.16 Gilead Sciences
14.17 GlaxoSmithKline
14.18 Helix
14.19 Immunocore
14.20 Incyte Corp.
14.21 Johnson & Johnson
14.22 Merck & Co., Inc.
14.23 Novartis Ag
14.24 Pfizer Inc.
14.25 Roche Holding Ag
14.26 Sanofi
14.27 Spectrum Pharmaceuticals, Inc.
14.28 Takeda
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • 3SBio
  • AbbVie, Inc.
  • Amgen
  • Astellas Pharma, Inc.
  • AstraZeneca
  • Bayer
  • BeiGene
  • Bristol-Myers Squibb
  • Celgene
  • Cernostics
  • Cerus Corporation
  • CHAIN Biotechnology
  • Daiichi Sankyo
  • DNALite Therapeutics, Inc.
  • Eli Lilly
  • Gilead Sciences
  • GlaxoSmithKline
  • Helix
  • Immunocore
  • Incyte Corp.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis Ag
  • Pfizer Inc.
  • Roche Holding Ag
  • Sanofi
  • Spectrum Pharmaceuticals, Inc.
  • Takeda